A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients | MicrobiomeTrials← Back to trialsNCT07635316
A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-12Est. Completion: 2027-02-25
Enrollment target: 4,023 participants ContactNovartis Pharmaceuticals
Other microbiome trials you might be interested in
GEP-NETGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine Tumor DiseaseNeuroendocrine TumorsCarcinoidCarcinoid TumorPancreatic NETSolid TumorSomatostatin Receptor
The primary objectives are to determine the recommended Phase 2 dose (RP2D) and optimal treatment regimen, characterize …
Iowa City, United StatesEst. completion Feb 2027
Other Neoplasms Solid Tumors
Pediatric Solid Tumor
Refractory Solid Tumors
Solid Tumor
Background:
Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors or…
Bethesda, United StatesEst. completion May 31, 2028